← All indications
Cachexia
General ill health, malnutrition, and weight loss, usually associated with chronic disease.
Drugs by status
Approved for this indication (2)
Phase 4 trials (3)
Phase 3 trials (13)
Phase 2 trials (24)
Phase 1 trials (14)
Organizations
Organization Involved with Phase 4 Indications (10)
- Zhejiang Kanglaite Pharmaceutical Co.Ltd
- Bristol-Myers Squibb
- Medical Research Council
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Huazhong University of Science and Technology
- Tufts University
- Pennsylvania State University
- University of Gothenburg
- H & J CRO International, Inc.
- Swedish Cancer Foundation
Organization Involved with Phase 3 Indications (33)
- Merck Serono
- Helsinn
- DSM
- GTx
- Par Pharmaceuticals
- XBiotech, Inc.
- National Cancer Institute (NCI)
- Cairo University
- Canadian Cancer Trials Group
- Johns Hopkins University
- Wake Forest University
- Mayo Clinic
- General Hospital Groeninge
- International Center for Diarrheal Disease Research
- Government of Mexico
- Pharmaceutical Research Associates, Inc. (PRA)
- Chengdu University of Traditional Chinese Medicines
- University of Sao Paulo
- Pacific Cancer Medical Center Inc.
- University of Nice Sophia Antipolis
- Summit Oncology Associates, Inc.
- Western Maryland Health System
- Innovative Medical Research of South Florida, Inc
- University of Texas, San Antonio
- MedQualis
- Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
- Forum Health
- Sanchez Cancer Center
- United Nations
- Ghent University
- +3 more
Organization Involved with Phase 2 Indications (73)
- Sapphire Therapeutics
- Acacia Pharma Ltd
- Daiichi Sankyo
- Theratechnologies
- Celgene
- Centocor
- Vivus
- AEterna Zentaris
- Novartis
- Anaborex
- Endo Pharmaceuticals
- GlaxoSmithKline
- Parexel
- Pinta Biotherapeutics
- PsiOxus Therapeutics Ltd
- Vicus Therapeutics
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Maastricht University
- Baylor University
- Cathay General Hospital
- Cedars-Sinai Medical Center
- Chang Gung University
- Changhua Christian Hospital
- Chung Shan Medical University
- University of London
- Chimei Medical Center
- Harvard University
- University of Washington
- National Cheng Kung University
- +43 more
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (28)
- Microbio Co Ltd
- National Center for Research Resources (NCRR)
- University of Pennsylvania
- Cancer Research UK
- Cancer Treatment Centers of America
- Eastern Cooperative Oncology Group
- McGill University
- Norwegian University of Science and Technology
- Osaka University
- University of Edinburgh
- University of Kansas
- University of Kentucky
- University of South Carolina
- University of Alberta
- University of Westminster
- Aalborg University
- Medical University of South Carolina
- All India Institute of Medical Sciences
- University of Freiburg
- National Taiwan University
- Winthrop University
- University of Erlangen-Nuremberg
- The Beatson West of Scotland Cancer Centre
- Hospital Erasto Gaertner
- Entera Health, Inc
- Queen Margaret Hospital, Dunfermline
- Malteser Krankenhaus Seliger Gerhardt
- University of Geneva